African Americans are significantly less likely to get a COVID-19 vaccination, and hesitancy is particularly prevalent in South Carolina and the Southeast U.S., a new survey says.
African Americans are significantly less likely to get a COVID-19 vaccination, and hesitancy is particularly prevalent in South Carolina and the Southeast U.S., a new survey says.
To address the problem, a number of South Carolina community organizations are developing a pubic health education campaign in communities where vaccine hesitancy remains prevalent.
While 28.5% of African Americans nationwide are “very likely” to receive the COVID-19 vaccine, only 19.3% of African Americans in the Southeast United States are also "very likely" to get it, according to the ADoH SCIENTIFIC survey.
On the other hand, 22.8% of African Americans in the Southeast say they are “very unlikely” to receive the vaccine, ADoH said in a press release.
Conversely, 50.7% of whites in the Southeast and 50.6% nationwide are “very likely” to receive a COVID-19 vaccine, according to the survey.
White respondents reported largely positive emotional responses to the prospect of vaccination, while African American respondents reported largely negative emotions.
“Fear is clearly a major driver of vaccine hesitancy, and not the only one,” said Dr. Brian Sullivan, PsyD, chief science officer at ADoH SCIENTIFIC. “It’s critically important to understand the variety and intensities of feelings driving this hesitancy.”
The data from ADoH SCIENTIFIC will be used by a consortium of South Carolina-based community organizations, including SCDHEC and Closing the Gap in Healthcare, to develop the “I Got It!” Campaign. The campaign will harness the emotional insights from the study to “dispel historical myths, engage the Black community, calm fears and inspire vaccine uptake,” said Tony Clark, director of community outreach and development at Closing the Gap in Healthcare.
“The COVID-19 crisis is hurting all our communities, but not equally. It is more important now than ever that we clearly communicate the importance of taking the COVID-19 vaccine to communities of color across the U.S, but particularly in Black communities in South Carolina and the Southeast,” said Dr. Kylon Jerome Middleton, senior pastor at Mount Zion African Methodist Episcopal Church and Charleston County Councilman - District 6.
Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study
March 18th 2024Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.
Read More
FDA Updates for Week of March 11: First CAR-T for CLL/SLL and First NASH Treatment
March 16th 2024The FDA this week approved a few firsts: the first treatment for NASH and the first CAR-T cell therapy for CLL/SLL. Other approvals include Tevimbra for esophageal cancer; Livmarli for second liver disease indication; and Praluent for children with genetic form of high cholesterol. The FDA also issued a CRL for monthly MS drug. Additionally, Celltrion submitted an application for an interchangeable Xolair biosimilar.
Read More
A Deep Dive into Predictive and Generative AI with Lynn Carroll of HSBlox
January 3rd 2024In this month’s episode, Briana Contreras, an editor of MHE, chatted with Lynn Carroll, executive of HSBlox, about the difference between predictive and generative AI, yet how each works together in preventive healthcare.
Listen
Transforming the management of genetic testing
March 15th 2024This e-book will explain where the current genetic test management system is inadequate and how a new approach designed specifically for genetic testing will perform better and provide more meaningful and actionable results.
Read More